Skip to main content
Clinical Trials/JPRN-jRCT2080224719
JPRN-jRCT2080224719
Completed
Phase 3

Multicenter trial of new coronary artery stenosis with Paclitaxel coated balloon catheter

IPRO CORPORATIO0 sites312 target enrollmentJune 10, 2019

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
IPRO CORPORATIO
Enrollment
312
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 10, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
IPRO CORPORATIO

Eligibility Criteria

Inclusion Criteria

  • Clinical inclusion criteria
  • \- Patient with stable or unstable angina pectoris or documented silent ischemia
  • \- Patient is eligible for percutaneous coronary intervention
  • \- Patient is acceptable candidate for CABG
  • Angiographic inclusion criteria (by visual estimation)
  • \- Native coronary artery
  • \- The lesions in the main coronary artery or in a branch of it
  • \- De novo lesion
  • \- Stenotic lesion
  • \- The stenosis of target lesion is 50% or more to less than 100%

Exclusion Criteria

  • Clinical exclusion criteria
  • \- Patients who have serious illness and may not be able to follow up as defined in the protocol
  • \- Patients who have a history of allergy or contraindications to Paclitaxel and the raw materials for clinical trial equipment (polyamide and Iopromide)
  • \- Not a suitable candidate for DAPT
  • \- Known allergy to contrast media
  • \- Low cardiac function or suspected, LVEF less than 30%
  • \- Patients with hepatitis or cirrhosis or their suspicion
  • \- Renal dialysis or with renal dysfunction (Cre \> 2\.0 mg / dL)
  • \- Patients with active peptic ulcer or gastrointestinal bleeding
  • \- Patients with a history of coronary artery spasm

Outcomes

Primary Outcomes

Not specified

Similar Trials